<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: drug companies</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Scientists advance understanding of brain receptor; may help fight neurological disorders</title>
   	 <description>For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.</description>
	  <link>http://medicalxpress.com/news/2013-05-scientists-advance-brain-receptor-neurological.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 28 May 2013 17:03:07 EST</pubDate>
	 <guid isPermaLink="false">news288979380</guid>
	 
</item>
<item>
     <title>Pharmaceutical companies: An $84 million marketing effort in the District of Columbia</title>
   	 <description>Drug companies spent nearly $84 million marketing pharmaceuticals in the District of Columbia in 2011, including an outlay of nearly $19 million for gifts given to physicians, hospitals and other health care providers, according to a report by researchers at the George Washington University School of Public Health and Health Services (SPHHS). The report notes that 12 physicians in the District received gifts (including consulting payments) that totaled more than $100,000 apiece that one year alone.</description>
	  <link>http://medicalxpress.com/news/2013-02-pharmaceutical-companies-million-effort-district.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 01 Mar 2013 00:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281290180</guid>
	 
</item>
<item>
     <title>Indian court to rule on generic drug industry</title>
   	 <description>(AP)—From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines.</description>
	  <link>http://medicalxpress.com/news/2013-01-indian-court-drug-industry.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 04 Jan 2013 04:57:22 EST</pubDate>
	 <guid isPermaLink="false">news276497833</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/indiancourtt.jpg" width="90" height="90" />
</item>
<item>
     <title>Court ruling may open door to more drug marketing</title>
   	 <description>A decision by a federal appeals court this week could have a dramatic impact on the marketing of prescription drugs in America, potentially affecting patient care and everything from TV drug advertising to future government prosecutions - prosecutions that have in the past yielded billions of dollars in settlements - doctors and attorneys said Tuesday.</description>
	  <link>http://medicalxpress.com/news/2012-12-court-door-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 06 Dec 2012 09:50:01 EST</pubDate>
	 <guid isPermaLink="false">news274004764</guid>
	 
</item>
<item>
     <title>Two drugs already on the market show promise against tuberculosis</title>
   	 <description>A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) &amp;#151; a disease that kills 2 million people annually &amp;#151; a scientist reported today at the 243 National Meeting &amp; Exposition of the American Chemical Society (ACS). The treatment, which combines two medications already approved by the U.S. Food and Drug Administration (FDA), delivers a knockout punch to forms of TB that shrug off other antibiotics.</description>
	  <link>http://medicalxpress.com/news/2012-03-drugs-tuberculosis.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 26 Mar 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news251983000</guid>
	 
</item>
<item>
     <title>Pot-based prescription drug looks for FDA OK</title>
   	 <description>A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant itself could soon be making their way to pharmacy shelves, according to drug companies, small biotech firms and university scientists.</description>
	  <link>http://medicalxpress.com/news/2012-01-pot-based-prescription-drug-fda.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 23 Jan 2012 04:05:13 EST</pubDate>
	 <guid isPermaLink="false">news246513892</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/potbasedpres.jpg" width="90" height="90" />
</item>
<item>
     <title>Boston lawsuit claims DES-breast cancer link</title>
   	 <description>(AP) --  Arline MacCormack first heard about DES from her mother when she was 17. Three decades later, MacCormack believes that the drug her mother took to prevent miscarriages caused her to develop breast cancer at age 44.</description>
	  <link>http://medicalxpress.com/news/2012-01-boston-lawsuit-des-breast-cancer-link.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 08 Jan 2012 16:44:14 EST</pubDate>
	 <guid isPermaLink="false">news245263394</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/bostonlawsui.jpg" width="90" height="90" />
</item>


</channel>
</rss>
